Combined limbal and corneal grafts: Should we or should we not?

Clinical and Experimental Ophthalmology

Volumn 36, Issue 6, 2008, Pages 497-498

  Dua, Harminder S ^a   Rahman, Imran ^a   Jayaswal, Rakesh ^a   Said, Dalia G ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ANTIMETABOLITE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS; VASCULOTROPIN INHIBITOR;

ALLOTRANSPLANTATION; COMORBIDITY; CORNEA TRANSPLANTATION; CORNEA VASCULARIZATION; DISEASE SEVERITY; DRY EYE; EDITORIAL; ELECTROLYSIS; EYE BURN; EYE DISEASE; EYE INFLAMMATION; FILTERING OPERATION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; LANGERHANS CELL; LIMBAL STEM CELL TRANSPLANTATION; LONG TERM CARE; PENETRATING KERATOPLASTY; RISK ASSESSMENT; RISK FACTOR; STEVENS JOHNSON SYNDROME;

CORNEAL TRANSPLANTATION; EYE BURNS; HUMANS; LIMBUS CORNEAE; SCLERA; TRANSPLANTATION, AUTOLOGOUS;

EID: 54049127398     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01841.x     Document Type: Editorial

References (16)

1. Joseph A, Raj D, Shanmuganathan V, Powell RJ, Dua HS. Tacrolimus immunosuppression in high-risk corneal grafts. Br J Ophthalmol 2007; 91: 51-5.
2. Coster DJ, Williams KA. Management of high-risk corneal grafts. Eye 2003; 17: 996-1002.
3. Maguire MG, Stark WJ, Gottsch JD et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994; 101: 1536-47.
4. Price FW Jr, Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991; 98: 322-8.
5. Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology 1998; 105: 1855-65.
6. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 2000; 41: 2148-53.
7. Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A. Subconjunctival bevacizumab injection for corneal neovascularization. Cornea 2008; 27: 142-7.
8. Shi W, Gao H, Wang T, Xie L. Combined penetrating keratoplasty and keratolimbal allograft transplantation in comparison with corneoscleral transplantation in the treatment of severe eye burns. Clin Experiment Ophthalmol 2008; 36: 501-7.
9. Dua HS, Azuara-Blanco A. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 2000; 84: 273-8.
10. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol 1999; 83: 414-19.
11. Kwitko S, Marinho D, Barcaro S et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology 1995; 102: 1020-5.
12. Rao SK, Rajagopal R, Sitalakshmi G, Padmanabhan P. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology 1999; 106: 822-8.
13. Solomon A, Ellies P, Anderson DF et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002; 109: 1159-66.
14. Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology 2002; 109: 1278-84.
15. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116: 431-41.
16. Shimazaki J, Maruyama F, Shimmura S, Fujishima H, Tsubota K. Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty. Cornea 2001; 20: 149-52.